The Latest Cardiac and Vascular News
Commercial Launch of VAZKEPA in Europe on Track to Commence in September in Germany Filed Several Market Access Dossiers in Europe with Proposed Pricing of approximately €200 per Month New CEO, Karim Mikhail, to Host Conference Call Today at 7:30 a.m. ET DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) […]
Second Quarter 2021 Revenue of $3.1 Million, a 150% Increase Over Prior Year MINNEAPOLIS, Aug. 04, 2021 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases, today announced its […]
WARREN, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the second quarter ended June 30, 2021. “We continue to progress […]
CONSHOHOCKEN, Pa., Aug. 05, 2021 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) reports today its second quarter 2021 financial results and provides a summary of corporate accomplishments. Paul Friedman, M.D., Chief Executive Officer of Madrigal, stated, “The Madrigal team has made great progress on multiple fronts in the first half […]
WEBSTER, Texas, Aug. 4, 2021 /PRNewswire/ — Corvion – developer of fully implanted mechanical circulatory support devices – announced today that William Cohn, MD and Sean Morris have been appointed to the company’s Board of Directors, effective immediately. Dr. Cohn currently serves as Vice President for Johnson & Johnson Medical Devices Companies and the Executive […]
Total revenue increased 23% to $12.0 million. Core non-COVID-19 product sales increased 38% Y-Y, driving overall Q2 2021 product sales to $11.4 million versus $9.5 million a year ago MONMOUTH JUNCTION, N.J., Aug. 3, 2021 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery […]
Funding Will Support the Company’s First Clinical Trial on its Path to Regulatory Clearance OR YEHUDA, Israel, Aug. 4, 2021 /PRNewswire/ — Append Medical, developer of the first no-implant minimally invasive solution for transcatheter Left Atrial Appendage (LAA) exclusion, today announced the completion of a $7.4 million Series A financing round. The round will enable Append […]
Headquartered in Canada, the company will manufacture in Costa Rica cardiovascular products to serve global markets. The 2.800 mts2 facility will be in La Lima Free Zone. CARTAGO, Costa Rica, Aug. 3, 2021 /PRNewswire/ — Baylis Medical, a Canadian company and leader in the development and commercialization of innovative medical devices in cardiology, announced today its […]
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on July 30, 2021 it granted stock options to purchase an aggregate of 258,750 shares of common stock to 15 new employees, whose employment commenced in July 2021, as a material inducement to […]
– U.S. Net Product Revenue of NEXLETOL® (bempedoic acid) Tablets and NEXLIZET® (bempedoic acid and ezetimibe) Tablets Grew 67% Sequentially to $10.6 Million – – Growth Driven by Increase in Demand and Substantial Improvement in Net Price – – Prescriptions Grew 28% During the Quarter; More Than 47,800 Patients Have Filled a Prescription for […]
